GREY:ATBPF - Post by User
Comment by
MrMugsyon Dec 30, 2020 11:55am
185 Views
Post# 32197576
RE:RE:RE:RE:RE:Good News
RE:RE:RE:RE:RE:Good NewsMrMugsy wrote: themagicbox wrote: Not to mention the new research coming out of the "university-that-cannot-be-named" discussed in the latest biopub. That will create both new IP and new patents that go far beyond the data protection and organge book patents for Oten/346.
The wild card will be what comes from the research on covid and if the different pipeline drugs have a therapeutic effect on COVID
I find COVID to be an interesting topic based on a few facts ...
1. They can't discuss details (other than an NDA, what other reason?). Could there be a partnership on this side.
2. Antibe is looking to get deeper into gaseous mediators and this alone spells exciting new approaches to dealing with inflamation, the root cause in some respects.
3. Think viruses and think gaseous mediators and I'm picturing opportunities for any virus down the road - even the common flu ????? Ya ya ... I'm dreaming - but Wallace has a chance to live his dream ... right here ... right now !!!!
4.
https://journals.physiology.org/doi/full/10.1152/ajpcell.00187.2020 Wonderdrug possibilites? I think one day we will look at gaseous mediators and say - what took us so long to get here ? Fingers crossed.
Oh ... as the article leads into ... even repairing damage to lungs. That gets us back full circle to OTENA and the reduction in ulceration. Next step after that ... repairing stomach ulcers. None of this is beyond ATE's abilities and ... I would bet ... Wallace has already travelled quite a distance down this road, with his iron sucking drugs to reduce pain associated with IBD.